A Closer Look At Egrifta, A Newly Approved Treatment For HIV-Associated Belly Fat Gain (Lipohypertrophy) TheBody.com: Podcast Central podcast

Artwork

Medicine Science Body Thebody.com HIV Aid TheBody Com

Indhold leveret af TheBody.com. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af TheBody.com eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

TheBody.com: Podcast Central « »
A Closer Look at Egrifta, a Newly Approved Treatment for HIV-Associated Belly Fat Gain (Lipohypertrophy)

13+ y ago 31:00

Del

MP3•Episode hjem

Indhold leveret af TheBody.com. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af TheBody.com eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

On Nov. 10, Egrifta (tesamorelin) became the first drug approved in the U.S. to treat unusual fat gain, or lipohypertrophy, in people with HIV. In our latest episode of This Month in HIV, we talk with noted HIV researcher Daniel Berger, M.D., about how Egrifta works, who should take it, and what else we know to date about the treatment of lipohypertrophy.

… continue reading

77 episoder

#Medicine #Science #Body #Thebody.com #HIV #Aid #TheBody #Com

Artwork

A Closer Look at Egrifta, a Newly Approved Treatment for HIV-Associated Belly Fat Gain (Lipohypertrophy)

TheBody.com: Podcast Central

published 13+ y ago

Del

MP3•Episode hjem

Indhold leveret af TheBody.com. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af TheBody.com eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

On Nov. 10, Egrifta (tesamorelin) became the first drug approved in the U.S. to treat unusual fat gain, or lipohypertrophy, in people with HIV. In our latest episode of This Month in HIV, we talk with noted HIV researcher Daniel Berger, M.D., about how Egrifta works, who should take it, and what else we know to date about the treatment of lipohypertrophy.

… continue reading

77 episoder

#Medicine #Science #Body #Thebody.com #HIV #Aid #TheBody #Com

Alle episoder

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner